The Cooper Companies, Inc. (COO) Gross Margin: 64.37%
Is The Cooper Companies, Inc.’s gross margin high or low?
The Cooper Companies, Inc.'s gross margin of 64.37% is in line with its 5-year average of 64.61%, around the middle of its 5-year range (60.67%–66.92%).
As of Sunday, June 14, 2026. 1.12% above its 12-month average of 63.66%.
COO Gross Margin Chart
COO Average Gross Margin Chart
COO Current vs Average Gross Margin Chart
COO Gross Margin Metrics
GROSS MARGIN
64.37%
GROSS MARGIN AVG TTM
63.66%
GROSS MARGIN AVG 3Y
64.40%
GROSS MARGIN AVG 5Y
64.61%
GROSS MARGIN AVG 10Y
63.76%
GROSS MARGIN AVG 15Y
63.28%
GROSS MARGIN AVG 20Y
62.02%
CURRENT VS TTM AVG
+1.12%
CURRENT VS 3Y AVG
-0.05%
CURRENT VS 5Y AVG
-0.37%
CURRENT VS 10Y AVG
+0.96%
CURRENT VS 15Y AVG
+1.73%
CURRENT VS 20Y AVG
+3.79%
COO Competitors' Gross Margin
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Cooper Companies, Inc. (COO) | $13.24B | 64.37% | 63.66% | 64.40% | 64.61% |
| Solventum Corporation (SOLV) | $13.66B | 53.67% | 54.56% | 56.03% | 57.27% |
| Align Technology, Inc. (ALGN) | $12.52B | 67.68% | 69.16% | 69.73% | 70.75% |
| Baxter International Inc. (BAX) | $10.77B | 30.11% | 33.76% | 35.72% | 36.84% |
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | 17.13% | 18.71% | 19.98% | 20.79% |
| Hologic, Inc. (HOLX) | $16.97B | 52.82% | 58.14% | 57.33% | 59.28% |
| Charles River Laboratories International, Inc. (CRL) | $9.03B | 31.86% | 31.70% | 34.15% | 35.17% |
| Tempus AI, Inc. (TEM) | $8.35B | 69.55% | 62.30% | 54.75% | 44.45% |
| Bio-Rad Laboratories, Inc. (BIO) | $7.73B | 51.87% | 52.87% | 53.77% | 54.60% |
| Moderna, Inc. (MRNA) | $19.80B | -13.89% | 54.80% | 53.09% | 65.45% |
Gross Margin Analysis
Gross Margin
64.4%
(Revenue - COGS) / Revenue
The Cooper Companies, Inc. Gross Margin Formula & Definition
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
The Cooper Companies, Inc. Gross Margin FAQ
- What is the gross margin for The Cooper Companies, Inc. (COO)?
- The gross margin for COO stock is 64.37%.
- Is The Cooper Companies, Inc.'s gross margin high or low?
- The Cooper Companies, Inc.'s gross margin of 64.37% is in line with its 5-year average of 64.61%, around the middle of its 5-year range (60.67%–66.92%).
- What is the TTM average gross margin for The Cooper Companies, Inc. (COO)?
- The TTM average gross margin for COO stock is 63.66%.
- What is the 3Y average gross margin for The Cooper Companies, Inc. (COO)?
- The 3Y average gross margin for COO stock is 64.40%.
- What is the 5Y average gross margin for The Cooper Companies, Inc. (COO)?
- The 5Y average gross margin for COO stock is 64.61%.
- What is the 10Y average gross margin for The Cooper Companies, Inc. (COO)?
- The 10Y average gross margin for COO stock is 63.76%.
- What is the 15Y average gross margin for The Cooper Companies, Inc. (COO)?
- The 15Y average gross margin for COO stock is 63.28%.
- What is the 20Y average gross margin for The Cooper Companies, Inc. (COO)?
- The 20Y average gross margin for COO stock is 62.02%.
The Cooper Companies, Inc. Gross Margin History
| DATE | GROSS MARGIN |
|---|---|
| 2025-10-31 | 60.67% |
| 2024-10-31 | 66.64% |
| 2023-10-31 | 65.62% |
| 2022-10-31 | 64.67% |
| 2021-10-31 | 66.92% |
| 2020-10-31 | 63.14% |
| 2019-10-31 | 66.21% |
| 2018-10-31 | 64.45% |
| 2017-10-31 | 63.85% |
| 2016-10-31 | 59.64% |
| 2015-10-31 | 59.56% |
| 2014-10-31 | 63.55% |
| 2013-10-31 | 64.67% |
| 2012-10-31 | 63.94% |
| 2011-10-31 | 60.47% |
| 2010-10-31 | 58.41% |
| 2009-10-31 | 55.21% |
| 2008-10-31 | 57.38% |
| 2007-10-31 | 54.65% |
| 2006-10-31 | 61.23% |
| 2005-10-31 | 61.59% |
| 2004-10-31 | 64.43% |
| 2003-10-31 | 64.40% |
| 2002-10-31 | 63.27% |
| 2001-10-31 | 65.38% |
| 2000-10-31 | 67.46% |
| 1999-10-31 | 66.03% |
| 1998-10-31 | 65.42% |
| 1997-10-31 | 45.30% |
| 1996-10-31 | 44.45% |
Related Metrics
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Albert G. White